TY  - BOOK
AU  - Canci,Jung Kyu
AU  - Mekler,Philipp
AU  - Mu,Gang
ED  - SpringerLink (Online service)
TI  - Quantitative Models in Life Science Business: From Value Creation to Business Processes 
T2  - SpringerBriefs in Economics,
SN  - 9783031118142
AV  - RA410-410.9 
U1  - 338.4761 23
PY  - 2023///
CY  - Cham
PB  - Springer International Publishing, Imprint: Springer
KW  - Medical economics
KW  - Pharmaceutical chemistry
KW  - Technological innovations
KW  - Medicine
KW  - Research
KW  - Biology
KW  - Biotechnology
KW  - Econometrics
KW  - Health Economics
KW  - Pharmaceutics
KW  - Economics of Innovation
KW  - Biomedical Research
KW  - Quantitative Economics
N1  - Part I. Value Creation and Managing Intellectual Property in the Life Science Industry -- Chapter 1. Value Creation, Valuation and Business Models in the Pharmaceutical Sector -- Chapter 2. Alternative Licensing Strategies: A Piecewise Deterministic Differential Game -- Chapter 3. Partnership Models for R&D in the Pharmaceutical Industry -- Part II. Modelling Specific Business Processes in the Life Science Industry -- Chapter 4. Pharma Tender Processes: Modelling Auction Outcomes -- Chapter 5. Multi-Echelon Inventory Optimization Using Deep Reinforcement Learning -- Part III. Specialized Quantitative Tools in the Life Science Industry -- Chapter 6. Stochastic Differential Equations in Healthcare -- Chapter 7. Point Processes with Mixed Doubly Stochastic Poisson and Self-Exciting Flavors: An Excursion Into DALY Computations; Open Access
N2  - This open access book explores the field of life science business from a multidisciplinary perspective. Applying statistical, mathematical, game-theoretic, and data science tools to pharmaceutical and biotechnology business endeavors, the book describes value creation, value maintenance, and value realization in the life sciences as a sequence of processes using the quantitative language of applied mathematics. Written by experts from a variety of fields, the contributions illustrate the shift from a deterministic to a stochastic view of the processes involved, offering a new perspective on life sciences economics. The book covers topics such as valuing and managing intellectual property in life science, licensing in the pharmaceutical business, outsourcing pharmaceutical R&D, and stochastic modelling of a pharmaceutical supply chain. The book will appeal to scholars of economics and the life sciences, as well as to professionals in chemical and pharmaceutical industries.
UR  - https://doi.org/10.1007/978-3-031-11814-2
ER  -